The influence of smoking on asthma in the real-life
- PMID: 32843181
- DOI: 10.1016/j.rmed.2020.106066
The influence of smoking on asthma in the real-life
Abstract
Background: Asthmatic smokers have reduced quality of life and need frequent specialist visits/hospitalization. Smoking habit represents for asthmatics a higher risk for comorbidities and lung function impairment. The impact of cigarette smoking on asthmatics should be addressed to evaluate the related risk factors.
Methods: This real-life observational study evaluated demographic, clinical/functional, and biological parameters of 521 asthmatic patients stratified as never (0 PY), light (1-10 PY), and heavy smokers (>10PY).
Results: The heavy smokers with asthma were more frequently older, male, overweight, and non-allergic than other asthmatics. Although similar ICS dose and severity among groups, heavy smokers had more significant airflow limitation (FEV1/FVC = 0.65 ± 0.10, p < 0.01; FEV1%pred = 79.20 ± 21.20, p < 0.01), air trapping (RV %pred. = 135.6 ± 44.8, p < 0.05; RV/TLC = 0.48 ± 0.12, p < 0.05), and fixed airflow obstruction (post-bronchodilation FEV1/FVC = 0.66 ± 0.10; p = 0.01) than never and light smokers with asthma. Heavy smokers also demonstrated reduced blood eosinophils (p < 0.05) and FeNO (p < 0.01), increased frequency of type-2 low inflammation and LABA/LAMA use but had less frequently persistent rhinitis and chronic rhinosinusitis with nasal polyposis. Heavy smokers showed higher prevalence of paraseptal/bullous emphysema and arterial hypertension. Considering the risk analysis, heavy smokers showed less chance to have allergy (OR = 0.5), persistent rhinitis (OR = 0.6), chronic rhinosinusitis with nasal polyposis (OR = 0.3), or high FeNO (OR = 0.4), but they were prone to develop fixed airflow obstruction (post-bronchodilation FEV1%pred<80%, OR = 2.0, and post-bronchodilation FEV1/FVC≤0.70, OR = 2.0).
Conclusions: Heavy smokers had more severe obstructive impairments than light and never smokers with similar ICS dose, showing a steroid insensitivity, but displayed less allergy with low FeNO and blood eosinophil count, thus being a definite phenotype.
Keywords: Airflow obstruction; Asthma; Chronic rhinosinusitis; Cigarette smoking.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).Respir Med. 2014 Dec;108(12):1723-32. doi: 10.1016/j.rmed.2014.10.007. Epub 2014 Oct 27. Respir Med. 2014. PMID: 25456708
-
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005. Zhonghua Nei Ke Za Zhi. 2016. PMID: 27586974 Chinese.
-
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.Chest. 2018 Mar;153(3):618-629. doi: 10.1016/j.chest.2017.11.016. Epub 2017 Nov 29. Chest. 2018. PMID: 29197547
-
Active smoking status in chronic rhinosinusitis is associated with higher serum markers of inflammation and lower serum eosinophilia.Int Forum Allergy Rhinol. 2014 May;4(5):347-52. doi: 10.1002/alr.21289. Epub 2014 Jan 15. Int Forum Allergy Rhinol. 2014. PMID: 24431239 Review.
-
The role of rhinosinusitis in severe asthma.Korean J Intern Med. 2013 Nov;28(6):646-51. doi: 10.3904/kjim.2013.28.6.646. Epub 2013 Oct 29. Korean J Intern Med. 2013. PMID: 24307837 Free PMC article. Review.
Cited by
-
Phenotype overlap in the natural history of asthma.Eur Respir Rev. 2023 May 17;32(168):220201. doi: 10.1183/16000617.0201-2022. Print 2023 Jun 30. Eur Respir Rev. 2023. PMID: 37197769 Free PMC article. Review.
-
Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life.Biomedicines. 2021 Nov 13;9(11):1684. doi: 10.3390/biomedicines9111684. Biomedicines. 2021. PMID: 34829913 Free PMC article.
-
Clinical characteristics of obese, fixed airway obstruction, exacerbation-prone phenotype and comorbidities among severe asthma patients: a single-center study.BMC Pulm Med. 2024 Feb 9;24(1):76. doi: 10.1186/s12890-023-02835-4. BMC Pulm Med. 2024. PMID: 38336682 Free PMC article.
-
Interleukin-35 inhibits NETs to ameliorate Th17/Treg immune imbalance during the exacerbation of cigarette smoke exposed-asthma via gp130/STAT3/ferroptosis axis.Redox Biol. 2025 May;82:103594. doi: 10.1016/j.redox.2025.103594. Epub 2025 Mar 12. Redox Biol. 2025. PMID: 40101533 Free PMC article.
-
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.Respir Res. 2024 Feb 28;25(1):104. doi: 10.1186/s12931-024-02710-8. Respir Res. 2024. PMID: 38419021 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical